About Us

A leading innovator of aesthetic and medical advanced laser and related technology, established over 20 years ago to bring intuitive, robust, versatile devices which are affordable and efficacious to the worldwide medical community.

Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customised treatments, which optimise outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 15% of revenues in R&D, Lutronic holds more than 270 current and pending patents.

With more than 250 employees worldwide, Lutronic has offices in the US, South Korea, China, and Japan, distributors world-wide, and is ever expanding.

Our Beginning up to Tomorrow

Intelligent Design for Intelligent Care

Confidence for the Practitioner… Improved Outcomes for the Patients.

Global Reach with a Local Touch

6 Continents
65 Countries

Many World Class Hospitals

Harvard Medical                                Osaka

MGH                                                  St. Petersburg

John Hopkins                                     Kiel-Hannover-Goettingen

Duke University                                  …Plus many more

9.4% Market Share

Lutronic is the 3rd largest global player in the skin rejuvenation market, showing year-over-year growth.

EXPERTS AGREE, LUTRONIC IS THE BEST IN THE AESTHETICS INDUSTRY

“Lutronic is one of the best hidden secrets in the aesthetic industry. Their systems are well built and reliable. The company is committed to building faster and more powerful devices across a wide spectrum of technology to building platforms.”

Omar Ibrahimi, MD, PhD
Connecticut – US